Human CTLA-4 (Research Grade Ipilimumab Biosimilar) Antibody, R&D Systems™

Catalog No.	Quantity
MAB9928-100	100 μg
MAB9928-SP	25 μg

Catalog No. MAB9928-100 Supplier R&D Systems Supplier No. MAB9928100

Description

Human Monoclonal Antibody

CTLA-4 Monoclonal specifically detects CTLA-4 in Human samples. It is validated for Flow Cytometry, CyTOF-ready.

Specifications

• Antigen: CTLA-4
• Applications: CyTOF, Flow Cytometry
• Classification: Monoclonal
• Clone: Hu111
• Conjugate: Unconjugated
• Dilution: Flow Cytometry 0.25μg/10⁶ cells, CyTOF-ready
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2μm filtered solution in PBS.
• Gene Alias: CD, CD152, CD152 antigen, CD152IDDM12, CD28, celiac disease 3, CELIAC3, CTLA4, CTLA-4, cytotoxic T-lymphocyte antigen 4, cytotoxic T-lymphocyte protein 4, Cytotoxic T-lymphocyte-associated antigen 4, cytotoxic T-lymphocyte-associated protein 4, cytotoxic T-lymphocyte-associated serine esterase-4, GRD4, GSE, ICOS, ligand and transmembrane spliced cytotoxic T lymphocyte associated antigen 4
• Host Species: Human
• Immunogen: Human CTLA-4
• Purification Method: Protein A or G purified from cell culture supernatant
• Quantity: 100 μg
• Primary or Secondary: Primary
• Gene ID (Entrez): 1493
• Test Specificity: Detects Human CTLA-4 based on Ipilimumab therapeutic antibody.This non-therapeutic antibody uses the same variable region sequence as the therapeutic antibody Ipilimumab. This product is for research use only.
• Reconstitution: Reconstitute at 0.5mg/mL in sterile PBS.
• Target Species: Human
• Content And Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
• Form: Supernatant
• Isotype: IgG1